K
Klaus Seppi
Researcher at Innsbruck Medical University
Publications - 366
Citations - 25650
Klaus Seppi is an academic researcher from Innsbruck Medical University. The author has contributed to research in topics: Parkinsonism & Medicine. The author has an hindex of 74, co-authored 317 publications receiving 20534 citations. Previous affiliations of Klaus Seppi include University of Innsbruck.
Papers
More filters
Journal ArticleDOI
Insulin signalling: new target for Parkinson's treatments?
Werner Poewe,Klaus Seppi +1 more
Journal ArticleDOI
Basal ganglia cellular pathology in multiple system atrophy, progressive supranuclear palsy and Parkinson disease. Can quantitative magnetic resonance spectroscopic imaging make the difference?
TL;DR: The results of the study suggest that patients with PSP and MSA-P have lower NAA concentrations in the pallidum, putamen and lentiform nucleus compared to healthy controls and patients with PD.
Journal ArticleDOI
The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach (vol 123, pg 439, 2016)
Johannes Levin,Sylvia Maass,Madeleine Schuberth,Gesine Respondek,Friedemann Paul,Ullrich Mansmann,Wolfgang H. Oertel,Stefan Lorenzl,Florian Krismer,Klaus Seppi,Werner Poewe,Gregor K. Wenning,Daniela Berg,Joseph Classen,Georg Ebersbach,Karla Eggert,Jan Kassubek,Axel Lipp,Matthias Loehle,Brit Mollenhauer,Alexander Muenchau,Martin Südmeyer,C. Blankenstein,C. Eberhardt,Birgit Ertl-Wagner,H. Heise,Ingrid Ricard,Armin Giese,Kai Boetzel,G. Hoeglinger,Promesa Study Grp +30 more
TL;DR: Johannes Levin • Sylvia Maaß • Madeleine Schuberth • Gesine Respondek • Friedemann Paul • Ullrich Mansmann • Wolfgang H. Oertel • Stefan Lorenzl • Florian Krismer • Klaus Seppi • Werner Poewe • Gregor Wenning • D. Blankenstein • C. Ertl-Wagner • H. Ricard • The PROMESA study group.
Journal ArticleDOI
M6 Nabilone in huntington’s disease: a case series of five patients
Beatrice Heim,Sweta Bajaj,Roberto De Marzi,Stephanie Mangesius,Atbin Djamshidian,Werner Poewe,Klaus Seppi +6 more
TL;DR: It is suggested that nabilone may be an effective and well tolerated adjunct to the drug treatment of HD, however, larger controlled trials are needed to confirm these preliminary open-label observations.
Journal ArticleDOI
Very late-onset pure autonomic failure.
Alessandra Fanciulli,Nadia Stefanova,Christoph Scherfler,Patrizia Moser,Klaus Seppi,Elke R. Gizewski,Irene Virgolini,Sylvia Boesch,Werner Poewe,Gregor K. Wenning +9 more
TL;DR: The manuscript was under revision, another study has reported the c.232C>T PDGFB mutation in a sporadic PFBC patient with memory impairment and headache to result in a deficiency of mature PDGF-BB.